-
Most Recent
Search Results
240 results for abv
China’s Shrinking Workforce = Your Biggest AI Opportunity Yet
While headlines stay fixated on chatbots and software, a deeper AI transformation is happening right now: Physical AI, or robots that learn and operate independently,…
A New Industrial Revolution Starts July 22 – Here’s Your Front-Row Seat
Not long ago, a video out of China started making the rounds. It showed a group of robots trying to play soccer. They tripped, collided,…
Robotics: Physical AI Is Here, and It’s Coming for a $50 Trillion Market
Robotics goes mainstream. From humanoids to AVs, Physical AI is poised to reshape labor and create massive new investment opportunities.
The Simple Trade That Made 100% in 19 Days
A few months ago, while most traders were panicking over President Trump’s tariff drama, veteran trader Jonathan Rose was quietly lining up what he calls…
Sovereign AI Gold Rush: How Governments Are Fueling a Tech Supercycle
Forget consumer apps. Sovereign AI is where the real money is flowing, forecasted to become a $50-billion-plus market over the coming years.
The Simple Trade That Made 100% in 19 Days
I’ve been a professional trader for almost 30 years. I’ve seen just about every kind of market you can imagine – the good, the bad,…
This Korean E-Commerce Giant Hit New Highs – Here’s Why I See Bigger Upside Ahead
Today, I want to highlight a company that contains multitudes itself. This company suffered a near 52-week low after Trump’s infamous April tariff announcement. But…
The Powerful Trading Strategy No One Else Is Teaching
While others panic when markets fall out of sync, veteran trader Jonathan Rose sees opportunity. That’s how, using his powerful divergence pattern, he’s helped his…
Our Computers Are Modeling a Raging Bull Market… in These 3 Stocks
Over the past several years, our team at TradeSmith has created a detailed system that models the likely next steps in a market. Now, they’re…
This Simple “Divergence” Pattern Made 100% in 19 Days
Today, Jonathan Rose will show you how divergence trades work… including the recent one that netted a 100% gain. First, let’s make sure you understand…
AI Trading Is Beating Wall Street at Its Own Game
By leveraging a powerful AI trading system, you can start to level the playing field with elite Wall Street firms.
AI vs. Wall Street: The Power Is Now in Your Hands
Today, Keith Kaplan will show you how TradeSmithGPT works, how it could completely change the way you build wealth in 2025 and beyond, and how…
Why Small-Caps Boom in June & What the Fed Just Signaled
As predicted, the Federal Reserve kept interest rates steady at the 4.25% – 4.5% range last week. But the big news came late on Saturday,…
The Robotaxi Wars Just Escalated. And It’s Only the Beginning…
In today’s Market360, I’ll show you who’s already in the fight, why this technology could upend entire industries and how investors can position themselves on…
Why Oil Prices Are Falling… and the Tool That Can Give You an Edge in a Chaotic Market
Today, Tom Yeung will consider Wall Street’s reaction to the Iran-Israel conflict… why traders might be far too optimistic in their risk assessment… and what…
ABM’s Dividend Increase Won’t Keep it Above $30
This morning I am recommending a bearish trade on ABM Industries, Inc. (NYSE:ABM), a provider of facility services like parking, janitorial services and building and…
NVIDIA Just Took Back the Crown – And I Told You This Was Coming
For some, it was too much to bear. But I stayed calm and urged restraint. And now? NVIDIA is not only back – it’s back…
Trade of the Day: AbbVie (ABBV)
In 2017, Humira raked in $18.9 billion in sales for AbbVie (ABBV) and, according to the company’s latest earnings announcement, that sales rate grew by…
Strong Buy for AbbVie (ABBV) This Week
AbbVie (ABBV) remains a Strong Buy this week based on the most current relative pricing of its shares and analysis.
Strong Buy for AbbVie (ABBV) This Week
The Strong Buy for AbbVie (ABBV) this week is based on the latest stock market rankings, and relative pricing of its shares.
Strong Buy for AbbVie (ABBV) This Week
At $114.93, AbbVie (ABBV) a Strong Buy based on the most recent SEC filings, and comparative pricing of its shares.
6 – 10 of 240 results
